Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Lewis Kahn / United States — Food and Drug Administration

Lewis Kahn & United States — Food and Drug Administration

2 shared events · Importance 3 · Last updated Apr 27, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
6.666666666666667
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (2)
40
Regulatory
ImmunityBio FDA Warning, Stock Drop
Lewis Kahn: Lewis Kahn is the Managing Partner of Kahn Swick & Foti, LLC, and is involved in reminding investors about the class action lawsuit.
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio, Inc. regarding misleading promotional communications for Anktiva, which led to the company's stock decline and subsequent lawsuit.
May 01, 2026 · 7 articles
0
Regulatory
UniQure FDA Dispute and Lawsuit
Lewis Kahn: Lewis Kahn is the Managing Partner at Kahn Swick & Foti, involved in the class action lawsuit against UniQure.
Apr 01, 2026 · 25 articles
NEWSDESK
Explore this relationship live

Track how Lewis Kahn and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.